The success of surgical management of lower pole stones is principally dependent on stone fragmentation and residual stone clearance. Choice of surgical method depends on stone size, yet all methods are subjected to post-surgical complications resulting from residual stone fragments. Here we present a novel method and device to reposition kidney stones using ultrasound radiation force delivered by focused ultrasound and guided by ultrasound imaging. The device couples a commercial imaging array with a focused annular array transducer. Feasibility of repositioning stones was investigated by implanting artiWcial and human stones into a kidney-mimicking phantom that simulated a lower pole and collecting system. During experiment, stones were located by ultrasound imaging and repositioned by delivering short bursts of focused ultrasound. Stone motion was concurrently monitored by Xuoroscopy, ultrasound imaging, and video photography, from which displacement and velocity were estimated. Stones were seen to move immediately after delivering focused ultrasound and successfully repositioned from the lower pole to the collecting system. Estimated velocities were on the order of 1 cm/s. This in vitro study demonstrates a promising modality to facilitate spontaneous clearance of kidney stones and increased clearance of residual stone fragments after surgical management.
Introduction
Optimal surgical management of lower pole calyx renal calculi remains a controversial topic as well as a treatment dilemma for the practicing urologist. In a prospective randomized clinical trial, the Lower Pole Study Group determined that the stone free rates for lower pole stones were signiWcantly better for patients treated with percutaneous nephrolithotomy as compared to extracorporeal shock wave lithotripsy (ESWL) with the largest observed diVerence seen in stones >1 cm in diameter [1] . With recent technological advancements, ureteroscopic management has shown stone free rates comparable to those of ESWL for stones <1 cm in diameter [2] .
Despite the evolution of technology-driven surgical approaches, the success in surgical management of lower pole stones is principally dependent on two processes: stone fragmentation and residual fragment clearance. The clinical need to establish complete stone clearance is highlighted by Chen and Streem [3] who prospectively followed 206 patients with isolated lower pole calculi treated with ESWL. This study concluded that post-ESWL, the probabilities of a symptomatic episode or requiring intervention at 5 years were 0.24 and 0.52, respectively.
Pelvic-caliceal anatomic factors including infundibulopelvic angle, infundibular length, and spatial orientation of caliceal anatomy have been identiWed as factors that may prospectively predict success of ESWL treatment for lower pole stones [4] . These anatomic factors have been proposed to hinder stone clearance and as such, percussion, diureses, and inversion therapy have all been proposed as adjunctive post-ESWL treatments to optimize stone clearance [5] [6] [7] .
To date, no research has been performed investigating the use of ultrasound radiation force as a mechanism to improve stone clearance and post-surgical stone free rates. We describe the development and in vitro testing of a prototype device that uses non-invasive ultrasound imaging to guide the application of focused ultrasound to move stones within the renal collecting system. The goal of this new device is to guide lower pole fragments out of a dependent caliceal position to a more superior position to facilitate spontaneous clearance of stone fragments.
Methods
Acoustic radiation force results from the transfer of acoustic wave momentum to an absorbing object, and is one example of a universal phenomenon associated with all forms of wave motion [8] . In the context of non-invasive repositioning of kidney stones and stone fragments in the lower pole and collecting system, the force acting on the stones is eVectively contained, because of the acoustic pressure proWle, within the focused beam and principally along the propagation axis. Therefore, with proper alignment of a focused beam upon a stone, it can be guided to a position that promotes spontaneous clearance or, for larger stones, increases the eYcacy of stone removal therapies. Figure 1 shows a schematic drawing of the hand-held probe for ultrasound-guided stone repositioning. It includes two ultrasound probes: a commercial imaging probe (HDI P4-2, Philips Healthcare, Andover, MA) and a focused ultrasound probe. An HDI 5000 (Philips Healthcare, Andover, MA) generated ultrasound images that were used to visualize and target the stones. The focused probe consists of an 8-element annular array with a nominal frequency of 2.0 MHz. Diameter of the active area was 63 mm and diameter of the inner imaging aperture was 20 mm. Array elements were driven by separate ampliWers and by adjusting phase delays, the focal depth was programmable within a range of 4.5-8.5 cm. Figure 2 shows a numerical simulation of the focused acoustic beam, and is exemplary of the spatial precision with which the stone-repositioning ultrasound can be delivered. Ultrasound was coupled to the tissue phantom by a water-Wlled standoV.
A kidney phantom was created using an optically transparent gel [9] . While the gel polymerized, a void to simulate a collecting system and lower pole was created using the cast of an 18F silicone Foley catheter. ArtiWcial stones, metal-plated glass beads from 2.5 to 4.0 mm in diameter, and human urinary calculi, from 3 to 8 mm in diameter, were placed dependently in the simulated collecting system. Figure 3 shows a photograph of an artiWcial stone within the kidney phantom. Human urinary calculi consisted of calcium oxalate and calcium hydrogen phosphate dihydrate (also known as brushite) and were >90% in purity. These stones were rehydrated for more than 24 h before experiment.
Once placed in the simulated lower pole, stones were located and visualized by ultrasound imaging. Coaxial arrangement of the imaging and focused probes permitted positioning of the device to locate the stone within the imaging plane and within the programed focal volume of the annular array. Focused ultrasound was then delivered at instantaneous acoustic power of 5-40 W, duty cycle of 50%, and duration of 2-5 s. Stone motion in the kidney phantom was concurrently monitored by Xuoroscopy and video photography, from which velocity, displacement, and trajectory were recorded. 
Results
In the kidney phantom, delivery of focused ultrasound resulted in stone motion from the lower pole into the collecting system. Stone motion was seen immediately after application of the focused ultrasound and stone velocity was on the order of 1 cm/s. Figure 4 shows Xuoroscopic images of an artiWcial stone's initial position in the lower pole, trajectory in response to focused ultrasound, and Wnal position within the collecting system. Stone motion and repositioning were observed for both artiWcial and human urinary stones and were independent of stone size. Operators could generally control the direction of stone displacement and we found that the best angle of focused ultrasound exposure was in line with the simulated infundibulum. However, this angle could be diYcult to determine extracorporeally.
All powers used moved the stones with essentially the same rate, but at least 10 W was required to lift the largest stone, 8 mm, all the way to the collecting system. As many as six stones placed in the collecting system at one time were all repositioned to the lower pole. Although energy was directed toward the collection of small stones and could lift slightly many stones at once, only one stone was repositioned to the collecting system with each pulse. Additionally, stone motion was not observed at all angles of focused ultrasound delivery. Angles of focus that were parallel to the axis of the simulated infundibulum resulted in larger displacement. Figure 5 shows ultrasound images analogous to the Xuoroscopy images in Fig. 4 , and demonstrates how the integration of ultrasound imaging and focused ultrasound can be used to detect and target residual stones, reposition them in the collecting system, and provide the user with real time visual feedback. Hyper-echogenic vertical bands on the edges of Fig. 5b resulted from delivery of focused ultrasound and illustrate how ultrasound imaging can be synchronized to maintain visualization of the stone. Figure 6 shows video photography monitoring analogous to Xuoroscopy and ultrasound.
Although this was an in vitro study to evaluate feasibility, the low potential of in vivo tissue injury can be assessed by comparing acoustic intensities to the limits determined by the FDA for diagnostic ultrasound imaging: I SPPA · 190 W/cm 2 to prevent cavitational injury and Fig. 3 Photograph of the kidney phantom with a simulated collecting system and lower pole. ArtiWcial and human stones were placed dependently in the lower pole, and were repositioned to the collecting system using the ultrasound-guided therapy device. The hand-held source was in contact with the lower side of the phantom with its axis aimed vertically through the phantom. Stone repositioning in the transparent phantom was monitored concurrently with Xuoroscopy, ultrasound imaging, and video photography Fig. 4 Fluoroscopy monitoring of an artiWcial stone that was repositioned from the lower pole into the collection system of a kidney phantom. Displacement of the stone was seen immediately after the application of focused ultrasound and the total distance traveled was approximately 1 cm. Estimated velocity magnitude was 1 cm/s ISPTA · 720 mW/cm 2 to prevent thermal injury [10] . Focal intensities can be estimated as total acoustic power delivered by the transducer per cross-sectional area of the focal beam width. A total power of 10 W, enough to lift the largest stone in this study, relates to focal intensity of 10/ 0.3 2 , or approximately 30 W/cm 2 . This is the spatial-averaged pulse-average intensity, I SAPA , that must be multiplied by 1.6 [11] to attain the spatial-peak pulse-averaged intensity, I SPPA , 45 W/cm 2 , which is lower than the FDA limit. The spatial-peak time-averaged intensity, I SPTA , is I SPPA multiplied by the temporal duty factor, 50%, or 23 W/cm 2 , which is higher than the FDA limit. However, because exposure times to reposition stones were 2-5 s, as opposed to 10 min for diagnostic ultrasound, the risk of thermal injury is low. As another point of comparison, intensities 2-3 orders of magnitude higher, I SPTA of 1,500-15,000 W/cm 2 , such as those used for high intensity focused ultrasound, are necessary to induce tissue necrosis during similar exposure times [12] .
Discussion
The goal of elective renal stone surgery is to render the patient stone free. Persistent renal fragments remaining 
during, and (c) after delivering focused ultrasound to move the stone from the lower pole to the collecting system of the kidney phantom. Blue artifacts were added to denote the axis of the focused array, and the red artifact shows its focus; (a) shows initial targeting of the stone. The lower pole appears at the top of these images because the hand-held device was in contact with the bottom of the phantom Fig. 6 Video photography monitoring of an artiWcial stone (a) before, (b) during, and (c) after delivering focused ultrasound after stone comminution is common after the treatment of lower pole stones due to their dependent position and pelvic-caliceal anatomic factors. We have described a novel ultrasound-guided therapy to aid in stone fragment expulsion.
As expected, larger stones were the most diYcult to reposition and perhaps this observation is due to higher stone mass as well as diYcult maneuvering past a narrow infundibular channel. This technology is not dependent on stone composition as a variety of common human calculi subtypes were able to be repositioned.
Advantages of this new technology include handheld portability, reusability, and no required sterilization. As ultrasound exposure has no known harmful side-eVects and is a painless exposure, the device could be potentially used in awake, non-anesthetized patients in a clinic or emergency room setting.
Potential applications for this device also include adjunctive use with primary medical expulsive therapy and the management of obstructing ureteropelvic junction stones by pushing the stone back into a nonobstructing location. The device may also be used in patients with known infectious stones where it has been well established that complete stone clearance is essential to prevent further stone formation as well as reduce the likelihood of recurrent infection. Lastly, this ultrasound-based device may also be used in the management of renal calculi in the pediatric and pregnant populations where there is greater concern over eVects of ionizing radiation [13] common to ureteroscopic, SWL, and percutaneous stone management.
